Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00435045Phase 3Completed
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, sponsored by GSK. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00435045.